肺癌とイレッサについて
A.1 胸部X線画像
A.2 胸部CT画像
A.3 血液検査
| 検査日 | GOT | GPT | KL-6 | CEA | CA19-9 | SCC | SLX | 体重 |
|---|---|---|---|---|---|---|---|---|
| 2012/08/03 | 2.7 | 1.8 | ||||||
| 2012/09/20 | 27.0 | 9.0 | ||||||
| 2012/09/21 | 22.0 | 9.0 | ||||||
| 2012/09/22 | 19.0 | 9.0 | ||||||
| 2012/09/24 | 38.0 | 35.0 | ||||||
| 2012/09/27 | 26.0 | 41.0 | ||||||
| 2012/10/01 | 17.0 | 22.0 | 150 | |||||
| 2012/10/04 | 16.0 | 15.0 | ||||||
| 2012/10/09 | 15.0 | 13.0 | 202 | 0.9 | 1.6 | |||
| 2012/10/15 | 15.0 | 10.0 | 186 | |||||
| 2012/10/29 | 82.0 | 161.0 | 182 | 56.1 | ||||
| 2012/11/12 | 86.0 | 163.0 | ||||||
| 2012/11/26 | 61.0 | 103.0 | 176 | 0.7 | 2.9 | 56.9 | ||
| 2012/12/17 | 32.0 | 51.0 | 176 | 1.0 | 2.0 | 58.7 | ||
| 2013/01/21 | 27.0 | 35.0 | 162 | 1.3 | 3.2 | 60.4 | ||
| 2013/03/01 | 18.0 | 18.0 | 167 | 60.8 | ||||
| 2013/03/25 | 24.0 | 30.0 | 185 | 1.3 | 3.6 | 1.7 | 60.5 | |
| 2013/06/20 | 21.0 | 20.0 | 157 | 1.0 | 4.4 | 2.2 | 61.6 | |
| 2013/07/04 | 20.0 | 21.0 | 154 | 0.9 | 2.3 | 1.8 | ||
| 2013/08/29 | 20.0 | 19.0 | 163 | 1.4 | 4.2 | 1.8 | 61.5 | |
| 2013/10/10 | 22.0 | 22.0 | 169 | 1.0 | 2.0 | 2.1 | 62.0 | |
| 2013/11/21 | 22.0 | 21.0 | 190 | 2.0 | 4.7 | 1.5 | 61.8 | |
| 2014/01/23 | 22.0 | 19.0 | 197 | 2.0 | 4.8 | 1.7 | 60.2 | |
| 2014/04/17 | 18.0 | 14.0 | 173 | 1.8 | 4.0 | 1.5 | 58.3 | |
| 2014/07/10 | 19.0 | 15.0 | 161 | 1.3 | 2.4 | 1.3 | 58.5 | |
| 2014/10/02 | 16.0 | 14.0 | 180 | 1.3 | 5.3 | 58.7 | ||
| 2015/02/05 | 23.0 | 21.0 | 2.2 | 5.7 | 21.0 | 58.0 | ||
| 2015/05/13 | 18.0 | 12.0 | 1.5 | 3.6 | 21.0 | 58.0 | ||
| 2015/07/23 | 22.0 | 17.0 | 1.6 | 20.0 | 57.0 | |||
| 2015/08/27 | 20.0 | 15.0 | 1.0 | 26.0 | 57.0 | |||
| 2015/09/18 | 19.0 | 15.0 | 1.0 | 20.0 | 57.0 | |||
| 2015/11/05 | 19.0 | 13.0 | 1.1 | 2.1 | 26.0 | 58.0 | ||
| 2015/12/08 | 27.0 | 16.0 | 1.2 | 1.7 | 23.0 | 58.0 | ||
| 2016/01/14 | 20.0 | 12.0 | 1.8 | 1.7 | 22.0 | 58.0 | ||
| 2016/02/16 | 21.0 | 13.0 | 1.3 | 2.7 | 20.0 | 60.0 | ||
| 2016/02/25 | 23.0 | 12.0 | 129 | 1.5 | 4.0 | 1.3 | 23.9 | 60.0 |
| 2016/05/17 | 15.0 | 9.0 | 1.3 | 1.5 | 58.0 | |||
| 2016/09/02 | 19.0 | 9.0 | 0.9 | 1.8 | 58.0 | |||
| 2016/10/25 | 26.0 | 18.0 | 1.3 | 1.5 | 58.0 | |||
| 2016/11/29 | 24.7 | 14.8 | 1.3 | 1.2 | ||||
| 2016/12/27 | 31.4 | 16.7 | ||||||
| 2017/2/21 | 21.9 | 14.8 | ||||||
| 2017/4/18 | 19.7 | 16.0 | ||||||
| 2017/6/20 | 19.8 | 14.3 | 60.0 | |||||
| 2017/8/8 | 17.1 | 13.2 | ||||||
| 2017/9/19 | 17.9 | 14.0 | ||||||
| 2017/11/14 | 35.7 | 20.8 | ||||||
| 2018/1/9 | 26.6 | 16.3 | ||||||
| 2018/3/6 | 30.9 | 25.1 | 60.5 | |||||
| 2018/5/1 | 23.3 | 14.7 | 60.8 | |||||
| 2018/6/26 | 19.7 | 17.0 | 58.0 | |||||
| 2018/8/21 | 21.2 | 13.3 | 55.1 | |||||
| 2018/10/16 | 34.0 | 22.0 | 1.5 | 2.3 | 54.5 | |||
| 2019/1/15 | 32.0 | 18.0 | 1.5 | 2.0 | 56.7 | |||
| 2019/6/28 | 23.0 | 14.0 | 1.4 | 1.8 | 57.5 | |||
| 2019/8/9 | 17.0 | 13.0 | 1.6 | 2.5 | 56.2 | |||
| 2019/12/16 | 14.0 | 11.0 | ||||||
| 2019/12/28 | 17.0 | 13.0 | ||||||
| 2020/1/31 | 21.0 | 16.0 | 1.2 | 60.6 | ||||
| 2020/7/21 | 22.0 | 16.0 | 2.5 | 55.2 | ||||
| 2020/9/25 | 22.0 | 18.0 | 2.3 | 53.7 | ||||
| 2021/1/23 | 24.0 | 20.0 | 3.0 | 53.2 | ||||
| 2021/5/11 | 21.0 | 17.0 | 55.2 | |||||
| 2021/6/4 | 23.0 | 17.0 | 55.5 | |||||
| 2021/7/6 | 19.0 | 14.0 | 4.8 | 55.2 | ||||
| 2021/8/5 | 19.0 | 14.0 | 7.3 | 54.3 | ||||
| 2021/9/7 | 23.0 | 19.0 | 8.6 | 55.2 | ||||
| 2021/10/5 | 22.0 | 15.0 | 9.6 | 54.9 | ||||
| 2021/11/2 | 21.0 | 14.0 | 9.8 | 55.2 | ||||
| 2021/11/16 | 24.0 | 17.0 | 55.4 | |||||
| 2022/1/6 | 21.0 | 12.0 | 1.4 | 56.9 | ||||
| 2022/3/8 | 25.0 | 16.0 | 1.2 | 54.6 | ||||
| 2022/6/21 | 28.0 | 21.0 | 52.9 | |||||
| 2022/12/20 | 28.0 | 20.0 | 1.2 | 54.2 | ||||
| 2023/2/17 | 23.0 | 18.0 | 0.9 | 53.0 | ||||
| 2023/4/21 | 35.0 | 29.0 | 1.0 | 53.1 | ||||
| 2023/6/23 | 23.0 | 21.0 | 1.2 | 53.3 | ||||
| 2023/8/4 | 27.0 | 25.0 | 0.9 | 53.6 | ||||
| 2023/8/25 | 37.0 | 50.0 | 53.4 | |||||
| 2023/9/15 | 37.0 | 62.0 | 0.9 | 53.9 | ||||
| 2023/10/6 | 31.0 | 43.0 | 0.8 | 54.1 | ||||
| 2023/11/10 | 33.0 | 31.0 | 1.2 | 55.9 | ||||
| 2023/12/15 | 25.0 | 18.0 | 1.6 | 57.3 | ||||
| 2024/2/16 | 21.0 | 14.0 | 1.8 | 58.1 | ||||
| 2024/4/27 | 23.0 | 16.0 | 3.4 | 56.3 | ||||
| 2024/6/1 | 24.0 | 18.0 | 5.7 | 57.6 | ||||
| 2024/8/31 | 21.0 | 12.0 | 1.5 | 56.6 | ||||
| 2024/11/09 | 18.0 | 12.0 | 1.5 | 57.5 |
間質性肺炎に関するマーカー（KL-6）
肝機能に関する数値（GOT、GPT）
腫瘍マーカー（CEA、シフラ、ProGRP）
体重
A.4 タルセバ、タグリッソ共通の副作用 ～下痢～
便数とその中の下痢数（2020/10/11～2023/6/14）
